Litigation Details for Melucci v. Corcept Therapeutics Incorporated (N.D. Cal. 2019)
✉ Email this page to a colleague
Melucci v. Corcept Therapeutics Incorporated (N.D. Cal. 2019)
Docket | ⤷ Sign Up | Date Filed | 2019-03-14 |
Court | District Court, N.D. California | Date Terminated | 2021-08-31 |
Cause | 15:78m(a) Securities Exchange Act | Assigned To | Lucy Haeran Koh |
Jury Demand | Plaintiff | Referred To | Susan G. Van Keulen |
Patents | 6,218,343 | ||
Link to Docket | External link to docket |
Biologic Drugs cited in Melucci v. Corcept Therapeutics Incorporated
Details for Melucci v. Corcept Therapeutics Incorporated (N.D. Cal. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-03-20 | 100 | Amended Complaint | $13,464,350.46 85.3% 10 2016 $6,218,343.16 $1,567,124.17 $4,651,218.99 …composition of matter patent has expired. Instead, Corcept relies on 10 patents covering the use of 19…covered by our patents. Although any such “off-label” use 8 would violate our patents, effectively…Corcept’s recently 21 issued ‘214 use patent 46 before the US Patent and Trademark Office (“USPTO”). On … only by a statutory stay pending 12 ongoing patent infringement litigation. 13 4. Despite | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |